Osseofuse International Inc. – FDA 483, Aug 26, 2021
Osseofuse International Inc., a medical device specification developer, was cited for significant deficiencies in its quality system during an FDA inspection. The firm failed to maintain adequate document control procedures, leading to the distribution of medical devices based on unapproved development plans, specifications, and risk management plans. Additionally, the inspection revealed that the firm's risk analysis was inadequate, with incorrect risk evaluations resulting in an under-estimation of risk acceptability for its dental implant systems.
ID · b35004cc-ff38-4cc8-badb-458e3c67437a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.